FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

FI Okoye

Research Profile

Disorders

Mammary Neoplasms, Experimental

Anatomy

Physiology

Genes & Molecular Sequences

Genes, erbB-2

Chemicals & Drugs

Living Beings

Procedures

Concepts & Ideas

T-Lymphocyte Subsets

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Jean-Pascal H Machiels; Richard T. Reilly; Leisha A Emens; Anne M Ercolini; RY Lei; D Weintraub; FI Okoye; Elizabeth M Jaffee
Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice.
Richard T. Reilly; Jean-Pascal H Machiels; Leisha A Emens; Anne M Ercolini; FI Okoye; RY Lei; D Weintraub; Elizabeth M Jaffee
The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors.
Richard T. Reilly; M B Gottlieb; Anne M Ercolini; Jean-Pascal H Machiels; C E Kane; FI Okoye; W J Muller; K H Dixon; Elizabeth M Jaffee
HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of FI Okoye (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2001: Jean-Pascal H Machiels; Richard T. Reilly; Leisha A Emens; Anne M Ercolini; RY Lei; D Weintraub; FI Okoye; Elizabeth M Jaffee
Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice.
Cancer research 2001;61(9):3689-97.
2001: Richard T. Reilly; Jean-Pascal H Machiels; Leisha A Emens; Anne M Ercolini; FI Okoye; RY Lei; D Weintraub; Elizabeth M Jaffee
The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors.
Cancer research 2001;61(3):880-3.
2000: Richard T. Reilly; M B Gottlieb; Anne M Ercolini; Jean-Pascal H Machiels; C E Kane; FI Okoye; W J Muller; K H Dixon; Elizabeth M Jaffee
HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice.
Cancer research 2000;60(13):3569-76.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.